This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Radiation Dermatitis Treatment Market

Radiation Dermatitis Treatment Market

Radiation Dermatitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2021 to 2031

Radiation Dermatitis Treatment Market
  • May-2021
  • List of Tables : 25
  • List of Figures : 132
  • 170 Pages
  • Healthcare

About the Report

The global radiation dermatitis treatment market is likely to reach a value of around US$ 700 million by 2031, expanding at a CAGR of approx. 5% during the forecast period. As adverse impacts of radiation therapy on the skin become evident, healthcare settings are providing solutions to mitigate these episodes, leading to incline in market growth. Demand for treatment of acute and chronic radio dermatitis is expected to surge over the coming years. Use of topical steroids for radiation dermatitis and topical corticosteroids for radiation dermatitis is also expected to witness an uptake.

Prominent stakeholders are majorly relying on traditional medicines, such as Traditional Chinese Medicine (TCM), so as to avoid any possible side-effects associated with using steroids or other allopathic drugs. Approaches such as honeysuckle treatment are proving highly effective in this regard. This new report by Fact.MR tracks global sales of radiation dermatitis treatment products in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare domain in general, and demand for radiation dermatitis treatment products in particular.

How Do Historical Trends Compare with Future Market Projections?

As the global incidence of cancers increase, healthcare providers are investing heavily in radiation therapy, attributed to its effectiveness in curing the most debilitating forms of cancers. However, this has led to an increase in radiation induced skin disorders, inclining demand for radiation dermatitis treatment products.

The radio dermatitis treatment market successfully outlasted the worst of the COVID-19 pandemic infection wave, as key manufacturers were able to maintain high inventory levels to cushion themselves from supply shocks induced by a sudden cessation of production activities. Future prospects appear bright with key players focusing on major innovations to incorporate technologies such as biocompatible and nanoparticle compounds.

Know More Details About the Report

How is Rising Prevalence of Cancer Driving Demand for Radiation Dermatitis Treatment?

According to the International Agency for Cancer Research (IARC), the number of new cancer cases rose to 19.3 million, with 10 million deaths during the year. By 2040, this number shall surpass 29 million, while deaths will increase to more than 16 million. Consequently, patients are seeking radiation treatment as it is highly effective in eradicating some of the worst cancers.

While radiation therapy accounts for 40% of all cancer cures globally, studies have indicated that patients receiving them are at heightened risk of suffering from radiation burns which induce numerous skin problems. Hence, uptake of radiation dermatitis dressings and treatment products is inclining across key regions.

What Prospects are in Store for Biocompatible & Biodegradable Nanomaterials?

Manufacturers are bolstering production capacities in wound dressings which are highly elastic and flexible. However, it has been found that these dressings in some cases may damage fragile skin and may not prevent maceration.

This has created a need for new biocompatible and biodegradable nanomaterials that help in regulating all phases of wound healing. Companies in the radiation dermatitis treatment market are increasing their R&D capabilities to develop dressings that incorporate antibacterial and self-healing properties.

Avail customized purchase options for your needs

How are Alternative Radiation Therapies Catalyzing Growth Prospects?

Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiation dermatitis by more accurately targeting tumor, thereby saving the normal tissue from repeated assault.

Higher adoption of these techniques, especially in developed regions, as they result in fewer severe rated cases of radiation dermatitis. This is likely to restrain uptake of chronic radiation dermatitis treatment products to a significant extent.

radiation dermatitis treatment market

Country-wise Analysis

How is Rising Skin Cancer Prevalence Stimulating Demand in the U.S.?

According to the Skin Cancer Foundation, more than 9,500 people in the U.S are diagnosed with skin cancer daily, with over 2/3rd of the people succumbing every hour. More than 5.4 million cases of non-melanoma skin cancer were treated in over 3.3 million people in 2012. Also, at least one in five Americans will develop skin cancer by the age of 70.

Hence, the scope for radiation dermatitis has increased in recent years. As per the American Society for Radiation Oncology (ASTO), nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, thus requiring treatment for the same, which is broadening avenues for the market.

Why is India an Emerging Market for Radiation Dermatitis Treatment?

In recent years, skin cancer prevalence has increased multifold within the Indian population, mostly attributed to surging urbanization rates, as the ozone layer over the country has significantly depleted. This has prompted patients to opt for skin cancer treatment, causing an increase in radiation dermatitis incidence.

Prominent manufacturers are increasingly capitalizing on topical agents manufacturing such as sucralfate creams, petroleum jellies, calendula, aqueous cream, and aloevera, among others. Various regional manufacturers currently operate within the Indian landscape, such as Radia Vit, Miaderm and Unitech Medical.

Will China Be a Lucrative Market for Radiation Dermatitis Treatment?

China is likely to offer highly attractive growth prospects, attributing to the ever-widening popularity of Traditional Chinese Medicine (TCM). TCM holds promising potentials in minimizing the impact of radio-dermatitis in patients with neck and head cancer.

Companies in the acute radiation dermatitis treatment market are capitalizing on this opportunity to innovate in pastes that improve the symptoms of skin reaction caused due to radiotherapy. Honeysuckle is emerging as one of the key ingredients in TCM for the treatment of carbuncles, while medicines containing angelica sinensis appear to nourish and activate the blood and relieve pain by promoting coronary circulation.

An Adaptive Approach to Modern-day Research Needs

Category-wise Insights

Why are Topical Hydrophilic Creams Attracting Attention?

By product, demand for topical hydrophilic creams is anticipated to surge impressively, attributed to its ease of application, cost-effectiveness and enhanced bioavailability. These creams impart moisture to prevent dry, rough, itchy and scaly skin.

Radiation treatment often eliminates moisture content from the skin, rendering it extremely dry and irritated, thus requiring high amounts of water to reduce this constant irritation. 3M Company, for instance, offers the CavilonTM Advanced Skin Protectant, comprising of a hydrophilic composition of elastomeric polymer and a non-stinging solvent.

Competitive Landscape

Prominent expansion strategies by key radiation dermatitis treatment product manufacturers involve introducing new products, acquiring and collaborating with existing players, and securing regulatory approvals.

  • In January 2021, Integra Lifesciences Holdings Inc. acquired ACell Inc. and its proprietary MatriStem UBMTM technology to further enhance its complex wound management solutions
  • In 2019, Molnlycke Health Care AB collaborated with Zuellig Pharma to strengthen its advanced wound care solutions across South East Asia. This follows the successful acquisition of SastoMed in July 2018, augmenting Mölnlycke’s range of wound care solutions with SastoMed’s ground-breaking, oxygen-therapy based solutions for chronic wounds

*This list is indicative - full details about key market players is available upon request.

Have a report related query? Speak to us directly

Report Scope



Forecast Period


Historical Data Available for


Market Analysis

US$ Mn for Value & ‘000 Units for Volume

Key Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Countries Covered

  • U.S
  • Canada
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC
  • South Africa

Key Segments Covered

  • Product
  • Distribution Channel
  • Region

Key Companies Profiled

  • 3M Company
  • Molnlycke Health Care AB
  • Smith & Nephew Plc
  • Integra Lifesciences Holdings Corporation
  • Intermed S.A.
  • ConvaTech Group Plc

Key Market Segments Covered

  • Product

    • Oral Medication-based Radiation Dermatitis Treatment
      • Corticosteroids
      • Oral Analgesics & Antibiotics
    • Topical Radiation Dermatitis Treatment
      • Corticosteroids
      • Hydrophilic Creams
      • Topical Antibiotics
    • Dressing-based Radiation Dermatitis Treatment
      • Hydrogel
      • Hydrocolloid
      • No Sting Barrier Film
      • Honey Impregnated Gauze
      • Silicone Coated Dressing
      • Others
  • Distribution Channel

    • Radiation Dermatitis Treatment through Hospital Pharmacies
    • Radiation Dermatitis Treatment through Retail Pharmacies
    • Radiation Dermatitis Treatment through Online Pharmacies
  • Region

    • North America
      • U.S
      • Canada
    • Europe
      • Germany
      • U.K
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Radiation Dermatitis Treatment Market - Scope of Report

A recent study by Fact.MR on the radiation dermatitis treatment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering radiation dermatitis treatment.

The study also provides the dynamics responsible for influencing the future status of the radiation dermatitis treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies involved in radiation dermatitis treatment, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of radiation dermatitis treatment across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of radiation dermatitis treatment products during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative radiation dermatitis treatment markets?
  • Which factors will impact the growth of the market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the radiation dermatitis treatment industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for radiation dermatitis treatment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global radiation dermatitis treatment market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the radiation dermatitis treatment market during the forecast period.

Country-specific valuation on demand for radiation dermatitis treatment market has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of radiation dermatitis treatment products, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in manufacturing radiation dermatitis treatment products has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the radiation dermatitis treatment market, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

- FAQs -

The global market for radiation dermatitis treatment is expected to reach nearly US$ 700 million by 2031, expanding at a steady CAGR of approximately 5% across the forecast period.
Demand for topic hydrophilic creams is expected to emerge the strongest, while topical corticosteroids are also expected to witness enhanced uptake over the coming years.
Although the United States is witnessing major uptake of radiation dermatitis treatment products, the Asia Pacific region shall generate lucrative revenue prospects, with countries such as China and India emerging as potential growth ecosystems.
3M Company, Molnlycke Health Care AB, Smith & Nephew Plc, and Integra Lifesciences Holdings Corporation are some prominent players offering radiation dermatitis treatment products.

Need an Exclusive Report for your Unique Requirement?

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.